Updated Jul 16, 2026
Grasman Jeroen Nicolaas has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jeroen Nicolaas Grasman is a financial executive known for his role as Chief Financial Officer at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His experience in finance and management has contributed to the company's strategic financial planning and operations.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 31.4K | $0.61 | $19K |
| 2026-03-18 | VXRT | Vaxart, Inc. | A — Grant or award | 227.0K | $0.00 |
Jeroen Nicolaas Grasman is a financial executive known for his role as Chief Financial Officer at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His experience in finance and management has contributed to the company's strategic financial planning and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Grasman Jeroen Nicolaas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.